Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized Trial

Despite significant progress in the treatment of pediatric acute myeloblastic leukemia (AML), relapse remains the commonest cause of death. Randomized ELAM02 trial questioned if maintenance therapy with interleukin-2 (IL2), for 1 year, improves disease-free survival (DFS). Patients aged 0 to 18 year...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Hemasphere
Main Authors: Petit, Arnaud, Ducassou, Stéphane, Leblanc, Thierry, Pasquet, Marlène, Rousseau, Alexandra, Ragu, Christine, Cachanado, Marine, Nelken, Brigitte, Bertrand, Yves, Michel, Gérard, Gandemer, Virginie, Cuccuini, Wendy, Fenneteau, Odile, Lapillonne, Hélène, Auvrignon, Anne, Baruchel, André, Leverger, Guy
Formáid: Artigo
Teanga:Inglês
Foilsithe: Wolters Kluwer Health 2018
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745961/
https://ncbi.nlm.nih.gov/pubmed/31723797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000159
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla